Need help finding what you are looking for?
Contact Us
PUBLISHER: Allied Market Research | PRODUCT CODE: 1645725
PUBLISHER: Allied Market Research | PRODUCT CODE: 1645725
Pharmaceutical Suppositories Market By Type, By Base, By Prescription Type, By Therapeutic Application, By Fill Volume Categories, By Age Group, By Distribution Channel, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035
PUBLISHED:
PAGES: 423 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The pharmaceutical suppositories market was valued for $1,668.09 million in 2023 and is estimated to reach $3,239.32 million by 2035, exhibiting a CAGR of 5.7% from 2024 to 2035.
Pharmaceutical suppositories are solid dosage forms designed for insertion into body cavities, where they dissolve or melt to release active ingredients. They are commonly formulated using a base material such as cocoa butter, glycerinated gelatin, or polyethylene glycol (PEG) and others, which provides stability and enables controlled drug release. The manufacturing process involves melting the base, mixing it with the active pharmaceutical ingredient (API) and any necessary excipients, and then molding the mixture into the desired shape. Once cooled, the suppositories solidify and are packaged for use. Suppositories are designed to deliver medication via mucosal absorption.
The pharmaceutical suppositories market is growing due to several key factors. The aging global population is driving demand, as elderly individuals often struggle with swallowing pills or require localized drug delivery. Additionally, the rising prevalence of chronic diseases like gastrointestinal disorders and certain cancers increases the need for targeted treatments that suppositories can provide. Further advancements in drug delivery have expanded the range of medications administered via suppositories, enhancing their effectiveness. For instance, a study published by National Library of Medicine in 2023, stated that, an azithromycin suppository administered through the rectal route demonstrated significantly increased bioavailability when compared with oral administration in pediatric population. Moreover, government initiatives promoting early diagnosis, along with pharmaceutical companies' efforts to raise public awareness of suppository benefits, further support market growth.
However, certain challenges hinder market expansion. Limited drug compatibility remains an issue, as not all medications are stable or effectively delivered through suppositories due to solubility concerns. Moreover, the complex manufacturing processes require specialized equipment, which increases production costs and limits the number of manufacturers. These factors contribute to restricted market accessibility and higher costs, impacting overall affordability. Despite these challenges, the demand for suppositories continues to rise, driven by their unique advantages in drug delivery.
The pharmaceutical suppositories market is segmented into type, base, prescription type, therapeutic application, fill volume categories, age group, ingredient type, distribution channel, and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. According to base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories. On the basis of therapeutic application, it is categorized into analgesics and anti-inflammatory drugs, antiemetics, laxatives, hormonal therapies, antifungals and antibacterials, and others. As per fill volume categories, it is divided into small fill volumes, medium fill volumes, and large fill volumes. On the basis of age group, it is bifurcated into pediatric use, and adult use. Depending on ingredient type, it is classified into active pharmaceutical ingredients, and excipients. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, the market is categorized into hospitals and clinics, home care, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players that operate in the pharmaceutical suppositories market include Zydus group, Bayer AG, Church & Dwight Co. Inc, Cosette Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., Sanofi S.A, Bliss GVS Pharma Ltd, and Bausch Health Companies Inc. The key players have adopted strategies such as product approval to expand their product portfolio.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical suppositories market analysis from 2023 to 2035 to identify the prevailing pharmaceutical suppositories market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the pharmaceutical suppositories market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global pharmaceutical suppositories market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
- Import Export Analysis/Data
Key Market Segments
By Prescription Type
- OTC
- Prescribed Suppositories
By Therapeutic Application
- Analgesics and Anti-Inflammatory Drugs
- Antiemetics
- Laxatives
- Hormonal Therapies
- Antifungals and Antibacterials
- Others
By Fill Volume Categories
- Small Fill Volumes
- Medium Fill Volumes
- Large Fill Volumes
By Type
- Rectal Suppositories
- Vaginal Suppositories
By Age Group
- Pediatric Use
- Adult Use
By Base
- Fatty Bases
- Water Miscible Base
- Type
- Glycero Gelatin Base
- Soap Glycerin Suppositories
- Polyethylene Glycol Bases
- Emulsifying Bases
- Type
- Witepsol
- Massa Esterium
- Massuppol
By Distribution Channel
- Hospital Pharmacies
- Drug Stores and Retail Pharmacies
- Online Providers
By End User
- Hospitals and Clinics
- Home Care
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East And Africa
Key Market Players:
- Bausch Health Companies Inc.
- Bayer AG
- Bliss GVS Pharma Ltd
- Church & Dwight Co. Inc.
- Cosette Pharmaceuticals, Inc.
- Intas Pharmaceuticals Ltd.
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Zydus Lifesciences Limited
Product Code: A12350
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter's five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in prevalence of acute & chronic disorders
- 3.4.1.2. Increase in the geriatric population
- 3.4.1.3. Increase in initiatives for awareness and education for use of suppositories
- 3.4.2. Restraints
- 3.4.2.1. Manufacturing complexities of pharmaceutical suppositories
- 3.4.2.2. Storage and stability issues of pharmaceutical suppositories
- 3.4.3. Opportunities
- 3.4.3.1. Technological advancements in formulation technology
- 3.4.1. Drivers
CHAPTER 4: PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Rectal Suppositories
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Vaginal Suppositories
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
CHAPTER 5: PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Fatty Bases
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Water Miscible Base
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.3.4. Water Miscible Base Pharmaceutical Suppositories Market by Type
- 5.4. Emulsifying Bases
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
- 5.4.4. Emulsifying Bases Pharmaceutical Suppositories Market by Type
CHAPTER 6: PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. OTC
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Prescribed Suppositories
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
CHAPTER 7: PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION
- 7.1. Overview
- 7.1.1. Market size and forecast
- 7.2. Analgesics and Anti-Inflammatory Drugs
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
- 7.3. Antiemetics
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
- 7.4. Laxatives
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
- 7.5. Hormonal Therapies
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by region
- 7.5.3. Market share analysis by country
- 7.6. Antifungals and Antibacterials
- 7.6.1. Key market trends, growth factors and opportunities
- 7.6.2. Market size and forecast, by region
- 7.6.3. Market share analysis by country
- 7.7. Others
- 7.7.1. Key market trends, growth factors and opportunities
- 7.7.2. Market size and forecast, by region
- 7.7.3. Market share analysis by country
CHAPTER 8: PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES
- 8.1. Overview
- 8.1.1. Market size and forecast
- 8.2. Small Fill Volumes
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by region
- 8.2.3. Market share analysis by country
- 8.3. Medium Fill Volumes
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by region
- 8.3.3. Market share analysis by country
- 8.4. Large Fill Volumes
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by region
- 8.4.3. Market share analysis by country
CHAPTER 9: PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP
- 9.1. Overview
- 9.1.1. Market size and forecast
- 9.2. Pediatric Use
- 9.2.1. Key market trends, growth factors and opportunities
- 9.2.2. Market size and forecast, by region
- 9.2.3. Market share analysis by country
- 9.3. Adult Use
- 9.3.1. Key market trends, growth factors and opportunities
- 9.3.2. Market size and forecast, by region
- 9.3.3. Market share analysis by country
CHAPTER 10: PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL
- 10.1. Overview
- 10.1.1. Market size and forecast
- 10.2. Hospital Pharmacies
- 10.2.1. Key market trends, growth factors and opportunities
- 10.2.2. Market size and forecast, by region
- 10.2.3. Market share analysis by country
- 10.3. Drug Stores and Retail Pharmacies
- 10.3.1. Key market trends, growth factors and opportunities
- 10.3.2. Market size and forecast, by region
- 10.3.3. Market share analysis by country
- 10.4. Online Providers
- 10.4.1. Key market trends, growth factors and opportunities
- 10.4.2. Market size and forecast, by region
- 10.4.3. Market share analysis by country
CHAPTER 11: PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER
- 11.1. Overview
- 11.1.1. Market size and forecast
- 11.2. Hospitals and Clinics
- 11.2.1. Key market trends, growth factors and opportunities
- 11.2.2. Market size and forecast, by region
- 11.2.3. Market share analysis by country
- 11.3. Home Care
- 11.3.1. Key market trends, growth factors and opportunities
- 11.3.2. Market size and forecast, by region
- 11.3.3. Market share analysis by country
- 11.4. Others
- 11.4.1. Key market trends, growth factors and opportunities
- 11.4.2. Market size and forecast, by region
- 11.4.3. Market share analysis by country
CHAPTER 12: PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION
- 12.1. Overview
- 12.1.1. Market size and forecast By Region
- 12.2. North America
- 12.2.1. Key market trends, growth factors and opportunities
- 12.2.2. Market size and forecast, by Type
- 12.2.3. Market size and forecast, by Base
- 12.2.4. Market size and forecast, by Prescription Type
- 12.2.5. Market size and forecast, by Therapeutic Application
- 12.2.6. Market size and forecast, by Fill Volume Categories
- 12.2.7. Market size and forecast, by Age Group
- 12.2.8. Market size and forecast, by Distribution Channel
- 12.2.9. Market size and forecast, by End User
- 12.2.10. Market size and forecast, by country
- 12.2.10.1. U.S.
- 12.2.10.1.1. Market size and forecast, by Type
- 12.2.10.1.2. Market size and forecast, by Base
- 12.2.10.1.3. Market size and forecast, by Prescription Type
- 12.2.10.1.4. Market size and forecast, by Therapeutic Application
- 12.2.10.1.5. Market size and forecast, by Fill Volume Categories
- 12.2.10.1.6. Market size and forecast, by Age Group
- 12.2.10.1.7. Market size and forecast, by Distribution Channel
- 12.2.10.1.8. Market size and forecast, by End User
- 12.2.10.2. Canada
- 12.2.10.2.1. Market size and forecast, by Type
- 12.2.10.2.2. Market size and forecast, by Base
- 12.2.10.2.3. Market size and forecast, by Prescription Type
- 12.2.10.2.4. Market size and forecast, by Therapeutic Application
- 12.2.10.2.5. Market size and forecast, by Fill Volume Categories
- 12.2.10.2.6. Market size and forecast, by Age Group
- 12.2.10.2.7. Market size and forecast, by Distribution Channel
- 12.2.10.2.8. Market size and forecast, by End User
- 12.2.10.3. Mexico
- 12.2.10.3.1. Market size and forecast, by Type
- 12.2.10.3.2. Market size and forecast, by Base
- 12.2.10.3.3. Market size and forecast, by Prescription Type
- 12.2.10.3.4. Market size and forecast, by Therapeutic Application
- 12.2.10.3.5. Market size and forecast, by Fill Volume Categories
- 12.2.10.3.6. Market size and forecast, by Age Group
- 12.2.10.3.7. Market size and forecast, by Distribution Channel
- 12.2.10.3.8. Market size and forecast, by End User
- 12.3. Europe
- 12.3.1. Key market trends, growth factors and opportunities
- 12.3.2. Market size and forecast, by Type
- 12.3.3. Market size and forecast, by Base
- 12.3.4. Market size and forecast, by Prescription Type
- 12.3.5. Market size and forecast, by Therapeutic Application
- 12.3.6. Market size and forecast, by Fill Volume Categories
- 12.3.7. Market size and forecast, by Age Group
- 12.3.8. Market size and forecast, by Distribution Channel
- 12.3.9. Market size and forecast, by End User
- 12.3.10. Market size and forecast, by country
- 12.3.10.1. Germany
- 12.3.10.1.1. Market size and forecast, by Type
- 12.3.10.1.2. Market size and forecast, by Base
- 12.3.10.1.3. Market size and forecast, by Prescription Type
- 12.3.10.1.4. Market size and forecast, by Therapeutic Application
- 12.3.10.1.5. Market size and forecast, by Fill Volume Categories
- 12.3.10.1.6. Market size and forecast, by Age Group
- 12.3.10.1.7. Market size and forecast, by Distribution Channel
- 12.3.10.1.8. Market size and forecast, by End User
- 12.3.10.2. France
- 12.3.10.2.1. Market size and forecast, by Type
- 12.3.10.2.2. Market size and forecast, by Base
- 12.3.10.2.3. Market size and forecast, by Prescription Type
- 12.3.10.2.4. Market size and forecast, by Therapeutic Application
- 12.3.10.2.5. Market size and forecast, by Fill Volume Categories
- 12.3.10.2.6. Market size and forecast, by Age Group
- 12.3.10.2.7. Market size and forecast, by Distribution Channel
- 12.3.10.2.8. Market size and forecast, by End User
- 12.3.10.3. UK
- 12.3.10.3.1. Market size and forecast, by Type
- 12.3.10.3.2. Market size and forecast, by Base
- 12.3.10.3.3. Market size and forecast, by Prescription Type
- 12.3.10.3.4. Market size and forecast, by Therapeutic Application
- 12.3.10.3.5. Market size and forecast, by Fill Volume Categories
- 12.3.10.3.6. Market size and forecast, by Age Group
- 12.3.10.3.7. Market size and forecast, by Distribution Channel
- 12.3.10.3.8. Market size and forecast, by End User
- 12.3.10.4. Rest of Europe
- 12.3.10.4.1. Market size and forecast, by Type
- 12.3.10.4.2. Market size and forecast, by Base
- 12.3.10.4.3. Market size and forecast, by Prescription Type
- 12.3.10.4.4. Market size and forecast, by Therapeutic Application
- 12.3.10.4.5. Market size and forecast, by Fill Volume Categories
- 12.3.10.4.6. Market size and forecast, by Age Group
- 12.3.10.4.7. Market size and forecast, by Distribution Channel
- 12.3.10.4.8. Market size and forecast, by End User
- 12.4. Asia-Pacific
- 12.4.1. Key market trends, growth factors and opportunities
- 12.4.2. Market size and forecast, by Type
- 12.4.3. Market size and forecast, by Base
- 12.4.4. Market size and forecast, by Prescription Type
- 12.4.5. Market size and forecast, by Therapeutic Application
- 12.4.6. Market size and forecast, by Fill Volume Categories
- 12.4.7. Market size and forecast, by Age Group
- 12.4.8. Market size and forecast, by Distribution Channel
- 12.4.9. Market size and forecast, by End User
- 12.4.10. Market size and forecast, by country
- 12.4.10.1. Japan
- 12.4.10.1.1. Market size and forecast, by Type
- 12.4.10.1.2. Market size and forecast, by Base
- 12.4.10.1.3. Market size and forecast, by Prescription Type
- 12.4.10.1.4. Market size and forecast, by Therapeutic Application
- 12.4.10.1.5. Market size and forecast, by Fill Volume Categories
- 12.4.10.1.6. Market size and forecast, by Age Group
- 12.4.10.1.7. Market size and forecast, by Distribution Channel
- 12.4.10.1.8. Market size and forecast, by End User
- 12.4.10.2. China
- 12.4.10.2.1. Market size and forecast, by Type
- 12.4.10.2.2. Market size and forecast, by Base
- 12.4.10.2.3. Market size and forecast, by Prescription Type
- 12.4.10.2.4. Market size and forecast, by Therapeutic Application
- 12.4.10.2.5. Market size and forecast, by Fill Volume Categories
- 12.4.10.2.6. Market size and forecast, by Age Group
- 12.4.10.2.7. Market size and forecast, by Distribution Channel
- 12.4.10.2.8. Market size and forecast, by End User
- 12.4.10.3. India
- 12.4.10.3.1. Market size and forecast, by Type
- 12.4.10.3.2. Market size and forecast, by Base
- 12.4.10.3.3. Market size and forecast, by Prescription Type
- 12.4.10.3.4. Market size and forecast, by Therapeutic Application
- 12.4.10.3.5. Market size and forecast, by Fill Volume Categories
- 12.4.10.3.6. Market size and forecast, by Age Group
- 12.4.10.3.7. Market size and forecast, by Distribution Channel
- 12.4.10.3.8. Market size and forecast, by End User
- 12.4.10.4. Rest of Asia-Pacific
- 12.4.10.4.1. Market size and forecast, by Type
- 12.4.10.4.2. Market size and forecast, by Base
- 12.4.10.4.3. Market size and forecast, by Prescription Type
- 12.4.10.4.4. Market size and forecast, by Therapeutic Application
- 12.4.10.4.5. Market size and forecast, by Fill Volume Categories
- 12.4.10.4.6. Market size and forecast, by Age Group
- 12.4.10.4.7. Market size and forecast, by Distribution Channel
- 12.4.10.4.8. Market size and forecast, by End User
- 12.5. LAMEA
- 12.5.1. Key market trends, growth factors and opportunities
- 12.5.2. Market size and forecast, by Type
- 12.5.3. Market size and forecast, by Base
- 12.5.4. Market size and forecast, by Prescription Type
- 12.5.5. Market size and forecast, by Therapeutic Application
- 12.5.6. Market size and forecast, by Fill Volume Categories
- 12.5.7. Market size and forecast, by Age Group
- 12.5.8. Market size and forecast, by Distribution Channel
- 12.5.9. Market size and forecast, by End User
- 12.5.10. Market size and forecast, by country
- 12.5.10.1. Latin America
- 12.5.10.1.1. Market size and forecast, by Type
- 12.5.10.1.2. Market size and forecast, by Base
- 12.5.10.1.3. Market size and forecast, by Prescription Type
- 12.5.10.1.4. Market size and forecast, by Therapeutic Application
- 12.5.10.1.5. Market size and forecast, by Fill Volume Categories
- 12.5.10.1.6. Market size and forecast, by Age Group
- 12.5.10.1.7. Market size and forecast, by Distribution Channel
- 12.5.10.1.8. Market size and forecast, by End User
- 12.5.10.2. Middle East And Africa
- 12.5.10.2.1. Market size and forecast, by Type
- 12.5.10.2.2. Market size and forecast, by Base
- 12.5.10.2.3. Market size and forecast, by Prescription Type
- 12.5.10.2.4. Market size and forecast, by Therapeutic Application
- 12.5.10.2.5. Market size and forecast, by Fill Volume Categories
- 12.5.10.2.6. Market size and forecast, by Age Group
- 12.5.10.2.7. Market size and forecast, by Distribution Channel
- 12.5.10.2.8. Market size and forecast, by End User
CHAPTER 13: COMPETITIVE LANDSCAPE
- 13.1. Introduction
- 13.2. Top winning strategies
- 13.3. Product mapping of top 10 player
- 13.4. Competitive dashboard
- 13.5. Competitive heatmap
- 13.6. Top player positioning, 2023
CHAPTER 14: COMPANY PROFILES
- 14.1. Intas Pharmaceuticals Ltd.
- 14.1.1. Company overview
- 14.1.2. Key executives
- 14.1.3. Company snapshot
- 14.1.4. Operating business segments
- 14.1.5. Product portfolio
- 14.2. Pfizer Inc.
- 14.2.1. Company overview
- 14.2.2. Key executives
- 14.2.3. Company snapshot
- 14.2.4. Operating business segments
- 14.2.5. Product portfolio
- 14.2.6. Business performance
- 14.3. Church & Dwight Co. Inc.
- 14.3.1. Company overview
- 14.3.2. Key executives
- 14.3.3. Company snapshot
- 14.3.4. Operating business segments
- 14.3.5. Product portfolio
- 14.3.6. Business performance
- 14.4. Zydus Lifesciences Limited
- 14.4.1. Company overview
- 14.4.2. Key executives
- 14.4.3. Company snapshot
- 14.4.4. Operating business segments
- 14.4.5. Product portfolio
- 14.4.6. Business performance
- 14.4.7. Key strategic moves and developments
- 14.5. Bayer AG
- 14.5.1. Company overview
- 14.5.2. Key executives
- 14.5.3. Company snapshot
- 14.5.4. Operating business segments
- 14.5.5. Product portfolio
- 14.5.6. Business performance
- 14.6. Novartis AG
- 14.6.1. Company overview
- 14.6.2. Key executives
- 14.6.3. Company snapshot
- 14.6.4. Operating business segments
- 14.6.5. Product portfolio
- 14.6.6. Business performance
- 14.7. Sanofi S.A.
- 14.7.1. Company overview
- 14.7.2. Key executives
- 14.7.3. Company snapshot
- 14.7.4. Operating business segments
- 14.7.5. Product portfolio
- 14.7.6. Business performance
- 14.8. Bliss GVS Pharma Ltd
- 14.8.1. Company overview
- 14.8.2. Key executives
- 14.8.3. Company snapshot
- 14.8.4. Operating business segments
- 14.8.5. Product portfolio
- 14.8.6. Business performance
- 14.9. Bausch Health Companies Inc.
- 14.9.1. Company overview
- 14.9.2. Key executives
- 14.9.3. Company snapshot
- 14.9.4. Operating business segments
- 14.9.5. Product portfolio
- 14.9.6. Business performance
- 14.10. Cosette Pharmaceuticals, Inc.
- 14.10.1. Company overview
- 14.10.2. Key executives
- 14.10.3. Company snapshot
- 14.10.4. Operating business segments
- 14.10.5. Product portfolio
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.